EyewireTV

04.17.2024

Watch Episode

Stocks

Sort by:

Change A-Z

AbbVie $165.41 0.46%

Adverum Biotechnologies $11.08 -0.63%

Alcon $79.50 1.31%

Aldeyra Therapeutics $3.90 -2.14%

Alimera Sciences $3.63 5.38%

Apellis Pharmaceuticals $47.11 -0.84%

Astellas Pharma $9.47 0.11%

Bausch + Lomb $14.53 1.47%

Bausch Health Companies $8.70 1.10%

Bayer $7.04 -0.21%

Biogen $190.93 0.22%

Can-Fite Biopharma $1.99 1.02%

Clearside Biomedical $1.42 7.58%

Cooper Companies $90.51 0.11%

Eyenovia $0.55 2.96%

EyePoint Pharmaceuticals $17.33 -0.97%

Glaukos $98.07 3.09%

Harrow Health $10.38 -4.33%

Hill-Rom $155.96 0.03%

Horizon Therapeutics $116.30 0.00%

InMed Pharmaceuticals $0.30 0.33%

Iridex Corporation $2.98 -1.32%

Johnson & Johnson $146.18 0.30%

Kala Pharmaceuticals $6.81 0.00%

Kiora Pharmaceuticals $0.51 0.75%

Lensar $3.14 2.61%

Lineage Cell Therapeutics $1.16 -3.33%

MeiraGTx Holdings $5.06 1.00%

Merck & Company $125.19 -0.03%

National Vision Holdings $18.52 -1.07%

NovaBay Pharmaceuticals $0.08 1.33%

Novartis AG Common Stock $93.89 1.43%

Ocugen $1.30 -1.89%

Ocular Therapeutix $5.09 -13.23%

Oculis $11.78 -1.01%

Ocuphire Pharma $1.69 1.20%

Omeros Corp. $3.15 -2.02%

Osmotica $1.11 -1.77%

Outlook Therapeutics $8.63 4.10%

Palatin Technologies $1.88 -0.79%

Regeneron $894.10 0.01%

Regenxbio $15.94 -1.06%

Roche $30.05 -0.10%

Sight Sciences $5.29 0.95%

STAAR Surgical Company $46.93 0.34%

Takeda Pharmaceutical Company $13.26 0.72%

Tarsus Pharmaceuticals $33.06 0.62%

Viatris $11.24 1.08%

View More Stocks

Cataract

Management of Advanced Glaucoma

Nathan M. Radcliffe, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

Eyetube

Nathan M. Radcliffe, MD, joins Blake Williamson, MD, MPH, and Gary Wörtz, MD, to share his experiences managing complex patients with advanced-stage glaucoma. He shares a specific case of an 83-year-old man with a cataract and exfoliation glaucoma with an IOP of 56 mm Hg. Dr. Radcliffe walks through how he managed complications he encountered during the combined cataract and glaucoma surgery, including vitreous prolapse and suprachoroidal hemorrhage. The surgeons also discuss how to educate and counsel patients with advanced-stage disease to help them understand realistic surgical outcomes.

Optimal IOP for the Stable Anterior Chamber

Hisaharu Suzuki, MD; Tsutomu Igarashi, MD; and Hiroshi Takahashi, MD

Eyetube

Novel Thermomechanical Adjustable IOL

Ruth Lapid-Gortzak, MD, and Vadim Shmukler, MD

Eyetube

A Model for Green Cataract Surgery

Kannusamy Veena, MD; Snigdha Mishra, MD; Rengaraj Venkatesh, MD

Eyetube

The Future of Hyperopic LASIK: Debates and Advances

William F. Wiley, MD, and Wesam Silk, MD

Eyetube

Dead Bag Syndrome

Lilianna Werner, MD, PhD; Jason Jones, MD; Nicole Fram, MD; Gregory Ogawa, MD; Samuel Masket, MD; and Nick Mamalis, MD

Eyetube

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.08.2024

Oculis Announces Positive Results from Phase 3 Trial of Once Daily Treatment for Inflammation and Pain Following Cataract Surgery

Eyewire News

Refractive

Hear the Journey of the OD Behind the Crystal Tear Report

Eyetube

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, catch up with Crystal M. Brimer, OD, FAAO, to talk about her prolific journey in dry eye. Dr. Brimer discusses opening her own practice, creating the Dry Eye Institute to promote education among eye care providers, and shares tips to help other ODs to get started or revitalize their dry eye services.

Synergizing Anterior and Posterior Expertise

Collaborating to improve patient outcomes.

Murtaza Adam, MD

Cataract and Refractive Surgery Today

An Eye to the Future

Steve Speares tells CRST what lies ahead for the ASCRS.

Gillian McDermott, MA, Editor-in-Chief, Clinical Content, Anterior Segment, BMC Vision

Cataract and Refractive Surgery Today

Keratoconus and Visual Rehabilitation

Two studies provide insight into current modalities.

Dimitrios Kyroudis, MD, FWCRS, and Michael Tsatsos, MD, PhD, FEBOS-CR, FWCRS, MRCOphth

Cataract and Refractive Surgery Today

The Future of Hyperopic LASIK: Debates and Advances

William F. Wiley, MD, and Wesam Silk, MD

Eyetube

Middle Segment Surgery

A new educational movement to train surgeons to meet a growing demand.

Cristos Ifantides, MD, MBA

Cataract and Refractive Surgery Today

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Stay Updated

Retina

Successful Management of Vitreous Opacities

Eyetube

Performing surgery for symptomatic vitreous opacities (SVO) was once verboten in retina medicine, but the field has seen a sea-change in mindset over the past decade. In this podcast, moderator John Kitchens, MD, is joined by Edwin H. Ryan, MD; Christina Y. Weng, MD, MBA; and Alison Bozung, OD, to explore why surgery for SVO has become more palatable and how this evolution in mindset is impacting patients' quality of life.

Determining When to Use Modifiers -58 and -78

Both are used in association with the original surgery, but ultimately serve different purposes.

Joy Woodke, COE, OCS, OCSR

Retina Today

Severe Diabetic Retinopathy With Epiretinal Fibrous Tissue and Tractional Retinal Detachment

Hudson Nakamura, MD

Eyetube

Research Considerations During Retina Fellowship

Two fellows offer their pearls to help others start their research journey.

Olufemi Adams, MD

Retina Today

The Importance of Serial OCT Scans in Tractional Retinal Detachment

Ahmed Abdelshafy, MD

Eyetube

Retina Education on the Atlantic Coast

The 2024 Atlantic Coast Retina Club and Macula Conference packed a punch with cases, lectures, and more.

Jacques Bijon, MD, and Erin Flynn, MD

Retina Today

04.18.2024

Ocular Therapeutix’ Axpaxli in Diabetic Retinopathy Evaluated in Phase 1 HELIOS Clinical Trial

Eyewire News

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

In Japanese Study, Vabysmo Achieves Primary Endpoint in Phase 3 Study for Angioid Streaks

Eyewire News

Glaucoma

Screening and Establishing a Diagnosis With OCT

Closer consideration of nonglaucomatous conditions is warranted.

Sanjay Asrani, MD

Glaucoma Today

OCT imaging has been proven to be an effective screening tool for glaucoma. In one study, investigators concluded that the quantitative parameters derived from OCT images, particularly vertical cup-to-disc ratio and retinal nerve fiber layer (RNFL) thickness, demonstrated sensitivities and specificities that were “adequately robust” for community glaucoma screening.1 Another study showed a fair level of agreement regarding glaucoma referral recommendations between glaucoma specialists with access to comprehensive screening data and OCT specialists with access to only OCT data.2 In 2022, however, Chou et al3 set out to update two reviews on glaucoma screening that were designed to inform the US Preventive Services Task Force. Their conclusions, which were published in JAMA, reported “limited direct evidence on glaucoma screening, showing no association with benefits.” The authors further noted that “screening tests can identify persons with glaucoma and treatment was associated with a lower risk of [glaucomatous] progression” but that “the evidence of improvement in visual outcomes, quality of life, and function remains lacking.” These conclusions were also published by the US Preventive Services Task Force in an Agency for Healthcare Research and Quality report.4 The bar is apparently set high to prove that glaucoma screening, although effective, indeed improves visual outcomes, patient quality of life, and function. This article reviews how best to use OCT to screen patients, establish a diagnosis, and actualize the many benefits of this diagnostic modality. ESTABLISHING A DIAGNOSIS Ophthalmologists have all come to rely on OCT. However, in the past few years, I have seen many pitfalls, related not only to misdiagnosis but also to codiagnosis, wherein the presence of other ocular pathology may be overlooked in the setting of glaucoma. One early pitfall relates to examining cup-to-disc asymmetry, the hallmark of glaucoma detection. In Figure 1A, the optic cups of the right and left eyes may seem similarly sized at first glance; however, bringing the images closer together to eliminate the distance between the optic cups reveals that the optic nerve of the right eye occupies more space within the green circle than the optic nerve of the left eye (Figure 1B). Side-by-side viewing can help to magnify subtle differences between optic nerves and reveal a case of nerve size asymmetry. This finding can be confirmed by the extreme symmetry of RNFL measurements between eyes (Figure 1C).

Hydrus Microstent Removal and Repositioning

I. Paul Singh, MD

Eyetube

Reflections on Fellowship So Far

With half a year behind them, current glaucoma fellows share their favorite pearls to date.

Viviana Barquet, MD; Gio Campagna, MD; Teresa Horan, MD; and Timothy Truong, MD

Glaucoma Today

Establishing a Glaucoma Practice Fresh Out of Fellowship

Insights and strategies for young ophthalmologists in building a successful, specialized practice.

Emily M. Schehlein, MD

Glaucoma Today

DARC: From Bench to Bedside

Tracing the path of an exploratory retinal biomarker.

Francesca M. Cordeiro, MD, PhD, MRCP, FRCOphth

Glaucoma Today

The Glaucoma Tension

Arsham Sheybani, MD

Glaucoma Today

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Pupil Pod

A case-based podcast hosted by Sila Bal, MD, MPH, featuring all stages of the journey through ophthalmology, from first-year residents to the leading experts.

View Feed

Optometry

The Mystery of Cilioretinal Arteries and AMD

Research is beginning to unravel the role these arteries play in the pathogenesis of neovascularization.

Adel Ebraheem, MD, MS, OD

Modern Optometry

Age-related macular degeneration (AMD) is a multifactorial condition characterized by dysregulation of the inflammatory, complement, lipid, and angiogenic pathways. AMD is classified as either dry or wet based on the absence or presence of choroidal neovascularization (CNV), respectively. Dry (nonexudative) AMD represents most of the total number of AMD cases.1 The hallmark of dry AMD is the presence of drusen, which can progress to geographic atrophy. Wet (exudative) AMD is characterized by invasion of the outer retina by new, immature blood vessels, or CNV, from the underlying choroid. The pathogenesis of wet AMD is the secretion of vascular endothelial growth factor (VEGF), which promotes the growth of these abnormal blood vessels. CNV can manifest as a retinal pigment epithelial detachment (PED), cystoid macular edema, hemorrhage, disciform scar, subretinal fluid (SRF), or a combination of these clinical features. IDENTIFYING CILIORETINAL ARTERIES The outer retina receives its blood supply from the choroid; the nutrients take a path through Bruch membrane and the retinal pigment epithelium to the neural retina. The central retinal artery is the main blood supply to the inner retina. The inner layers of the macula may receive a second blood supply from cilioretinal arteries, which emerge from the choroidal vascular bed (Figure). Cilioretinal arteries typically originate from the temporal margin of the optic disc, although they can also occasionally originate near the nasal border.

Successful Management of Vitreous Opacities

Eyetube

Interprofessional Collaboration Pays Off

Working alongside a patient’s primary care physician, the author was able to diagnose Sjögren syndrome and refer her for proper care.

Naureen M. Haroon, OD, MPH, FAAO

Modern Optometry

The Parasympathetic Nervous System and DED

The connection between the two suggests dry eye is more than just a disease of the eye.

Hardeep K. Kataria, OD, FAAO, and Mila Ioussifova, OD, FAAO, CNS

Modern Optometry

Don’t “Lump” All Lid Lesions Together

Be thorough in creating your differential diagnosis.

Jacob Lang, OD, FAAO

Modern Optometry

Technology in Collaborative Care: Friend or Foe?

Leveraging advances in optometry will help deliver more optimal, efficient patient care.

Selina R. McGee, OD, FAAO

Modern Optometry

04.10.2024

Orbis Partners and Heidelberg Engineering Partner to Train Eye Care Professionals Around the World

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.05.2024

Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Study

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Business

Tips for Retaining Staff and Keeping Them Happy

A solid team is at the core of any successful practice. Here’s how you can do your part as a leader to ensure employee satisfaction.

Michael J. Cymbor, OD, FAAO; Mila Ioussifova, OD, FAAO, CNS; and Caitlin Morrison, OD, FAAO, FSLS

Modern Optometry

Having trouble with employee turnover, or just want to be proactive so you (hopefully) never have to deal with it? We spoke with three established practice owners and asked them to share their secrets to building and maintaining a strong optometric team in today’s world. Read their insights for retaining staff and keeping them happy and productive. — Alex Brodin, Associate Editor Modern Optometry (MOD): Tell us about your practice. Mike Cymbor, OD, FAAO: Nittany Eye Associates has five locations in Pennsylvania. We employ 12 optometrists, one ophthalmologist, 18 technicians, and more than 60 staff members. Mila Ioussifova, OD, FAAO, CNS: South Waterfront Eye Care is a full-scope optometric practice with a boutique optical. We provide medical eye care with a special emphasis on dry eye disease management, offering advance treatments such as intense pulsed light therapy, radiofrequency, TearScience LipiFlow Thermal Pulsation System (Johnson & Johnson Vision), TearCare System (Sight Sciences), and MiBo ThermoFlo (MiBo Medical Group). We perform in-office procedures, including blood draws for autologous serum and platelet-rich plasma eye drop preparations, and offer aesthetic services. As a certified nutrition specialist, I offer personalized nutrition counseling tailored to enhance ocular health.

Achieving Staffing Excellence

Master this cornerstone of practice success by defining each staff member’s specific role.

Jason E. Compton, OD, FAAO

Modern Optometry

Comparing AI-Generated Answers to Patients’ Eye Care Questions With Ophthalmologists’ Responses

Robert T. Chang, MD; and Neda Shamie, MD

Eyetube

The State of Optometry’s Financial Health

Five takeaways from the largest income survey conducted in optometry.

Aaron Neufeld, OD

Modern Optometry

Expand Your Opportunities for Profitability

Consider adding these technologies to your practice and reap the rewards.

Christopher Lopez, OD

Modern Optometry

A Global Community

Callan Navitsky, Editor-in-Chief

Glaucoma Today

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.16.2024

EyeSouth Partners Affiliates With Community Eye Care Specialists in New York

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

False Claims Act Complaint Filed Against Regeneron for Fraudulent Drug Pricing Reporting

Eyewire News

EyewireTV

04.17.2024

04.17.2024

Executive Updates

Bausch + Lomb

Alcon

AbbVie

Tarsus Pharmaceuticals

Centricity Vision

Sydnexis

Azura Ophthalmics

iOR Partners

Eyewire News

Ocular Therapeutix’ Axpaxli in Diabetic Retinopathy Evaluated in Phase 1 HELIOS Clinical Trial

Aqueous Humor Proteome Database Established by Medical College of Georgia

Schwind Names Lohith Shetty Head of Global Marketing

Stocks

Cataract

Management of Advanced Glaucoma

Optimal IOP for the Stable Anterior Chamber

Novel Thermomechanical Adjustable IOL

A Model for Green Cataract Surgery

The Future of Hyperopic LASIK: Debates and Advances

Dead Bag Syndrome

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

04.08.2024

Oculis Announces Positive Results from Phase 3 Trial of Once Daily Treatment for Inflammation and Pain Following Cataract Surgery

Refractive

Hear the Journey of the OD Behind the Crystal Tear Report

Synergizing Anterior and Posterior Expertise

An Eye to the Future

Keratoconus and Visual Rehabilitation

The Future of Hyperopic LASIK: Debates and Advances

Middle Segment Surgery

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Stay Updated

Follow Eyewire News

Retina

Successful Management of Vitreous Opacities

Determining When to Use Modifiers -58 and -78

Severe Diabetic Retinopathy With Epiretinal Fibrous Tissue and Tractional Retinal Detachment

Research Considerations During Retina Fellowship

The Importance of Serial OCT Scans in Tractional Retinal Detachment

Retina Education on the Atlantic Coast

04.18.2024

Ocular Therapeutix’ Axpaxli in Diabetic Retinopathy Evaluated in Phase 1 HELIOS Clinical Trial

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

In Japanese Study, Vabysmo Achieves Primary Endpoint in Phase 3 Study for Angioid Streaks

Glaucoma

Screening and Establishing a Diagnosis With OCT

Hydrus Microstent Removal and Repositioning

Reflections on Fellowship So Far

Establishing a Glaucoma Practice Fresh Out of Fellowship

DARC: From Bench to Bedside

The Glaucoma Tension

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Featured Podcasts